{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:28:06Z","timestamp":1789450086585,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.vaccine.2006.03.092","type":"journal-article","created":{"date-parts":[[2006,4,25]],"date-time":"2006-04-25T02:58:04Z","timestamp":1145933884000},"page":"1912-1920","source":"Crossref","is-referenced-by-count":25,"title":["Improved immunogenicity of a H44\/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870"],"prefix":"10.1016","volume":"25","author":[{"given":"Oliver","family":"Koeberling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Anne","family":"Welsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.03.092_bib1","series-title":"Vaccines","article-title":"Meningococcal vaccines","author":"Granoff","year":"2003"},{"issue":"8346","key":"10.1016\/j.vaccine.2006.03.092_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.092_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/IAI.65.3.1045-1052.1997","article-title":"Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys","volume":"65","author":"Devi","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.092_bib4","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"Jodar","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2006.03.092_bib5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2006.03.092_bib6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0264-410X(96)00001-1","article-title":"Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine","volume":"14","author":"Peeters","year":"1996","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.092_bib7","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.185.7.1173","article-title":"Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection","volume":"185","author":"Martin","year":"1997","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.092_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/IAI.65.1.55-63.1997","article-title":"Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains","volume":"65","author":"Rokbi","year":"1997","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.092_bib9","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.092_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.092_bib11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2006.03.092_bib12","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"issue":"5459","key":"10.1016\/j.vaccine.2006.03.092_bib13","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.092_bib14","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.092_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein Factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.03.092_bib16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","article-title":"The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies","volume":"73","author":"Giuliani","year":"2005","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2006.03.092_bib17","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine","volume":"172","author":"Welsch","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.092_bib18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/432102","article-title":"Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen, 1870","volume":"192","author":"Hou","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2006.03.092_bib19","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1128\/IAI.71.12.6844-6849.2003","article-title":"Conformational epitopes recognized by protective anti-neisserial surface protein a antibodies","volume":"71","author":"Hou","year":"2003","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.092_bib20","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1128\/IAI.70.11.6021-6031.2002","article-title":"Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains","volume":"70","author":"Moe","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.03.092_bib21","first-page":"113","article-title":"Teasing apart structural determinants of \u2018toxicity\u2019 and \u2018adjuvanticity\u2019: implications for meningococcal vaccine development","volume":"10","author":"Steeghs","year":"2004","journal-title":"J Endotoxin Res"},{"issue":"9","key":"10.1016\/j.vaccine.2006.03.092_bib22","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/JB.184.9.2379-2388.2002","article-title":"Endotoxin of Neisseria meningitidis composed only of intact lipid A: inactivation of the meningococcal 3-deoxy-D-manno-octulosonic acid transferase","volume":"184","author":"Tzeng","year":"2002","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2006.03.092_bib23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3201\/eid1004.030247","article-title":"PorA variable regions of Neisseria meningitidis","volume":"10","author":"Russell","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.092_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/CDLI.5.3.348-354.1998","article-title":"Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system","volume":"5","author":"Sacchi","year":"1998","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06003999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06003999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T03:19:42Z","timestamp":1586834382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06003999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0264410X06003999"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.03.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}